Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol Infusion Effects on Muscle O2 Supply in Aging
NCT04181606Phase 1Completed
- Start
- Feb 2022
- Primary completion
- Apr 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of esmolol in aging (2 arms). Primary endpoint: Tissue Saturation Index - Active Leg Muscle. Started Feb 2022; status: completed.
02
Drugs
esmolol
03
Conditions
aging
Beyond the preview
Go deeper on NCT04181606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04181606.